Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:26:45 EST Sun 15 Nov 2026
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR+ Search
SEDAR+ Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR+ Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
News last 24 hour(s) - 13 items
News Releases
In The News
Other
CA
US
Date
Sym
Price
Type
Headline
2026-11-15 15:00
U
U:IDYA
News Release
200
IDEAYA Biosciences Announces Development Candidate Nomination of IDE101, a Potential First-In-Class Inhibitor Targeting CDKN2A-Deficiency in Solid Tumors
2026-11-15 13:00
U
U:DRTS
News Release
200
Alpha Tau Announces New Positive Interim Results from its U.S. Alpha DaRT(TM) Recurrent Glioblastoma Trial: All Patients Treated are Alive with Median Survival Not Reached, 6.9 Months Median Follow-Up in the First Six Evaluable Patients With 100% ORR, 100
2026-11-15 12:50
U
U:CCL
News Release
200
Princess Cruises Commemorates Inaugural Season at Celebration Key with Star Princess
2026-11-15 12:50
U
U:CCL
News Release
200
Princess Cruises Commemorates Inaugural Season at Celebration Key with Star Princess
2026-11-15 12:30
U
U:ELEK
News Release
200
IT'S TIME TO SHINE: ELEKTROS Thanks Its Shareholders and Looks Toward a Brighter Future in Critical Minerals and EV Technology
2026-11-15 12:20
U
U:ELEK
News Release
200
ELEKTROS Invites Shareholders to Shine Bright as the Holiday Season Nears, with Focus on Lithium, Critical Minerals and EV Innovation
2026-11-15 12:10
U
U:ELEK
News Release
200
As the Most Wonderful Time of the Year Approaches, ELEKTROS Celebrates Its Shareholders and Looks Ahead to a Bright Future
2026-11-15 12:05
U
U:VKTX
News Release
200
Viking Therapeutics Highlights Clinical Data from VK2735 Obesity Program at ObesityWeek(TM) 2026
2026-11-15 12:00
U
U:HELP
News Release
200
Helus Pharma to Present Topline Results from Phase 3 APPROACH Study Evaluating HLP003 as Adjunctive Treatment in Major Depressive Disorder on November 16, 2026
2026-11-15 10:00
U
U:CVS
News Release
200
CVS Health study highlights GLP-1 benefits and the affordability challenge
2026-11-15 07:00
U
U:OPK
News Release
200
Cocrystal Pharma Provides Business Update and Reports Third Quarter 2026 Financial Results
2026-11-15 07:00
U
U:LXEO
News Release
200
Lexeo Therapeutics to Report Third Quarter 2026 Financial Results and Provide LX2020 Business Update on November 16, 2026
2026-11-15 07:00
U
U:COCP
News Release
200
Cocrystal Pharma Provides Business Update and Reports Third Quarter 2026 Financial Results